Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand

NCT00261209 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2016-04-21

No results posted yet for this study

Summary

The purpose of this study is to dissolve flexor tendon adhesions associated with failed tendon repair surgery.

Conditions

  • Adhesion of Flexor Tendon of Hand

Interventions

DRUG

Collagenase

Collagenase injection into adhesion restricting tendon gliding

DRUG

Collagenase injection

injection of collagenase into adhesion restricting tendon gliding

Sponsors & Collaborators

Principal Investigators

  • Marie A Badalamente, PhD · Dept. Orthopaedics, SUNY@Stony Brook, NY 11794

  • Edward Wang, MD · Dept. Orthopaedics, SUNY@Stony Brook, NY 11794

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00261209 on ClinicalTrials.gov